The search for the mdr1-1Δ mutation of the MDR1 gene in four canine breeds in Uruguay (preliminary study)


Rosa Gagliardi B
Diana Martínez A
Beatriz Tellechea H
Pedro Sitjar Q
Silvia Llambí D
María Arruga L

Objective. The objective of this study is to analyze the frequency of mdr1-1Δ mutation in German Shepherd, Doberman, Border Collie and Greyhound dog breeds in Uruguay. Materials and methods. A total of 95 animals from the four breeds mentioned above were studied. DNA was isolated from blood using potassium acetate with a subsequent degradation from RNA with RNAsaH. The concentration and quality of the DNA obtained was evaluated with a Nanodrop, ND-1000 spectrophotometer. To determine the presence or absence of the mdr1-1Δ mutation, DNA samples were sent to Gene Seek, Neogen Corporation of Chicago, United States, for genotyping. Results. In all 95 animals studied, the mdr1-1Δ mutation was not present. Conclusions. Based on the preliminary results obtained, other elements that may cause adverse drug reactions must be considered: unidentified mutations in other regions of the MDR1 gene; mutations in other genes involved in the transport of drugs from the same subfamily or another; mutations in enzymes involved in drug metabolism (e.g. Cytochrome P450). Moreover, especially with Border Collies and Greyhounds, it is advisable to increase the number of animals in the study.

Key words: Dogs, ivermectine, P-glycoprotein (Source: CAB).

Palabras clave


Los datos de descargas todavía no están disponibles.


Referencias / Ver

Merola V, Khan S, Gwaltney-Brant S. Ivermectin toxicosis in dogs: A restrospective study. J Am Anim Hosp Assoc 2009; 45 (3):106-111.

Gramer I, Leidolf R, , DÓ§ring B, Klintzsch S, Krämer E-M, Yalcin E, Petzinger E, Geyer J. Breed distribution of the nt230 (del4) MDR1 mutation in dogs. Vet J 2011; 189 (1):67-71.

Geyer J, Klintzsch S, Meerkamp K, Wöhlke A, Distl O, Moritz A, Petzinger E . Detection of the nt230 (del4) MDR1 mutation in White Swiss Shepherd dogs: case reports of doramectin toxicosis, breed predisposition, and microsatellite analysis. J Vet Pharmacol Therap 2007; 30 (5):482-485.

Roulet A, Puel O, Gesta S, Lepage J-F, Drag M, Soll M, Alvinerie M, Pineau T. MDR1-deficient genotype in Collie dog hypersensitive to the Pglycoprotein substrate ivermectin. European J of Pharmacol 2003; 460 (2-3):85-91.

Mealey KL, Bentjen SA, Gay JM, Canthor GH. Ivermectin sensitivity in collies is associated with a deletion mutation of the MDR1 gene. Pharmacogenetics 2001; 11 (8):727-733.

Fraga J, Rodríguez J, Fuentes O, Castex M, Fernández-Calienes A. Comparación entre 5 métodos para la extracción de ADN de triatomíneos: su utilización en la técnica de ADN polimórfico amplificado al azar Rev Cubana Med Trop 2004; 56 (3):208-13.

Mealey KL. Farmacogenetica. Clin Vet NA Med Peq Anim 2006; 36 (5):961-973.

Neff MW, Robertson KR, Wong AK, Safra N, Broman KW, Slatkin M, Mealey KL, Pedersen NC. Breed distribution and history of canine mdr1-1Δ a pharmacogenetic mutation that marks the emergence of breed from the collie lineage. Proc Nat Acad Sci 2004; 101 (32):11725-11730.

Bissonnette S, Paradis M, Daneau I, Silverside DW. The ABCB1-1Δ mutation is not responsible for subchronic neurotoxicity seen in dogs of noncollie breeds following macrocyclic lactone treatment for generalized demodicosis. Vet Dermatol 2008; 20(1):60-66.

Geyer J, DÓ§ring B, Godoy JR, Leidolf R, Moritz A, Petzinger E. Frecuency of the nt230 (del4) MDR1 mutation in Collies and related dog breeds in Germany. J Vet Pharmacol Therap 2005; 28 (6):545-551.

Gagliardi R, García C, Llambí S, Arruga MV. Analysis of mdr1-1Δ mutation of MDR1 gene in the "Cimarron Uruguayo" dog. Rev MVZ Córdoba 2013; 18(2):3480-3483.

Gagliardi R. Estudios geneticos en caninos de raza Cimarron Uruguayo (Canis familiaris). [Tesis de Maestría]. Montevideo: Universidad de la República, Programa de Desarrollo de las Ciencias Básicas (PEDEClBA); 2009.

Tomiyasu H, Goto-Koshino Y, Fujino Y, Ohno K, Tsujimoto H. Epigenetic regulation of the ABCB1 gene in drug-sensitive and drug-resistant lymphoid tumour cell lines obtained from canine patients. Vet J 2014; 199 (1): 103-109.

Citado por